Clinically Apparent Atrial Fibrillation Increases Stroke Risk; Does Subclinical AFib Do the Same?

Published Online: Tuesday, January 14, 2014
Follow Pharmacy_Times:
Stuart J. Connelly, MD, one of the principal authors of “Subclinical Atrial Fibrillation and the Risk of Stroke,” published in the New England Journal of Medicine, talks about the study.  

To listen to the podcast, click here.
Related Articles
Teva has launched a generic version of aspirin and extended-release dipyridamole (Aggrenox) capsules in the United States.
A practice-changing study suggests bridging anticoagulation does more harm than good in atrial fibrillation (AF) patients treated with warfarin.
Studies have reported that up to half of patients discontinue prescribed therapies soon after hospital discharge.
Here are new drugs for 2015 pharmacists can expect to handle.
Latest Issues
$auto_registration$